Omega 3 acid ethyl esters Comprehensive patent search

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Shoppers Drug Mart Corporation : Retailing - Company Profile, SWOT and Financial Report

Shoppers Drug Mart Corporation : Retailing - Company Profile, SWOT and Financial Report

  • $ 125
  • Company report
  • by Canadean Ltd
  • September 2014
  • 42 pages

Synopsis Canadean's "Shoppers Drug Mart Corporation : Retailing - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, ...

Industries: Drug and Medication | Countries: Canada

SAPPORO DRUG STORE CO.,LTD. - Company Capsule, Canadean Ltd

SAPPORO DRUG STORE CO.,LTD. - Company Capsule, Canadean Ltd

  • $ 99
  • Company report
  • by Canadean Ltd
  • September 2014
  • 22 pages

Synopsis Canadean's "SAPPORO DRUG STORE CO.,LTD. - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis, key employees as well ...

Industries: Pharmacies and Drug Stores | Countries: Japan

Bangladesh Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Bangladesh Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 110 pages

BMI View: Bangladesh’s pharmaceutical market, which was worth US Dollar 1.40bn in 2010, is fairly typical for South Asia. Growth is high, but per-capita spending remains low. The industry is also characterised by the ability of those on high incomes to purchase expensive patented drugs, while the vast ...

Industries: Drug and Medication | Countries: Bangladesh

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 91 pages

BMI View: In terms of its attractiveness to investors, Slovenia remains a mid-tier pharmaceutical industry within Emerging Europe. While not immune from economic factors and government austerity drives, reforms to limit drug industry expenditure have been relatively limited when compared with the stringent ...

Industries: Drug and Medication | Countries: Slovenia

Iran Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Iran Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 115 pages

BMI View: We see room for moderate growth in Iran's pharmaceuticals market over the medium term and projection the industry growing at a compound annual rate of 6.88% (in US dollar terms) through to 2015. We also expect the country to become more reliant on pharmaceutical imports over the next three ...

Industries: Drug and Medication | Countries: Iran

Kazakhstan Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Kazakhstan Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 93 pages

BMI View: Kazakhstan remains by far the most transparent and accessible pharmaceutical industry in Central Asia and the government has shown a clear intent to reform the segment, albeit by increasing the role of the state. The Kazakhstani pharmaceutical segment remains dominated by imports, although ...

Industries: Drug and Medication | Countries: Kazakhstan

United States Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

United States Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 122 pages

BMI View: The US pharmaceutical industry is under increasing pressure. The faltering economy and precarious fiscal situation mean the government has fewer funds for healthcare programmes such as Medicaid – a scheme for those on low incomes. Suppressed consumer spending will also negatively affect the ...

Industries: Drug and Medication | Countries: United States

Ireland Pharmaceuticals and Healthcare Report Q4 2014

Ireland Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 78 pages

Includes 3 FREE quarterly updates BMI View: The US government and the OECD recent proposals to discourage corporate inversion pose downside risk to the rate of M&A deals that opt to establish their new headquarters' domicile in Ireland, although the megatrend of consolidation within the pharmaceutical ...

Industries: Prescription Drug | Countries: Ireland

Austria Pharmaceuticals and Healthcare Report Q4 2014

Austria Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 68 pages

Includes 3 FREE quarterly updates BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of these sectors in particular. The United States Commerce department has listed Austria as one of the ...

Industries: Drug and Medication | Countries: Austria

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 56 pages

A textual analysis of the financial results for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security ...

Industries: Pharmaceutical

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.